Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Apr 7;4(4):e230493.
doi: 10.1001/jamahealthforum.2023.0493.

A Prescription for Achieving Equitable Access to Antiobesity Medications

Davene R Wright  1 , Jingchuan Guo  2 , Inmaculada Hernandez  3
Affiliations

A Prescription for Achieving Equitable Access to Antiobesity Medications

Davene R Wright et al. JAMA Health Forum. .
No abstract available

Plain language summary

This Viewpoint discusses newer antiobesity medications that hold promise and how uneven access to these medications could exacerbate obesity disparities.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: Dr Guo reported personal fees from Pfizer outside the submitted work. Dr Hernandez reported personal fees from Bristol Myers Squibb and Pfizer outside the submitted work. No other disclosures were reported.

References

    1. Ogden CL, Fakhouri TH, Carroll MD, et al. Prevalence of obesity among adults, by household income and education–United States, 2011-2014. MMWR Morb Mortal Wkly Rep. 2017;66(50):1369–1373. doi:10.15585/mmwr.mm6650a1 - DOI - PMC - PubMed
    1. Atlas S, Beinfeld M, Lancaster V, et al. Medications for obesity management: effectiveness and value; final evidence report. Institute for Clinical and Economic Review. 2022. Accessed March 14, 2023. https://icer.org/wp-content/uploads/2022/03/ICER_Obesity_Final_Evidence_...
    1. Collazo-Clavell ML. Managing obesity: scaling the pyramid to success. Mayo Clin Proc. 2019;94(6):933–935. doi:10.1016/j.mayocp.2019.04.011 - DOI - PubMed
    1. Gadde KM, Allison DB, Ryan DH, et al. Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase3 trial. Lancet. 2011;377(9774):1341–1352. doi:10.1016/S0140-6736(11)60205-5 - DOI - PubMed
    1. Neumann PJ, Ganiats TG, Russell LB, Sanders GD, Siegel JE, eds. Cost-Effectiveness in Health and Medicine. 2nd ed. Oxford University Press; 2016. doi:10.1093/acprof:oso/9780190492939.001.0001 - DOI

Substances